Ray continued, “We’re also delighted to recognize Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology were instrumental to shaping the event of STK-012, our very first-in-class alpha/beta biased IL-2. Its special mechanism expands the therapeutic index of IL-2, considered one https://httpswwwzosanopharmacomte20864.blogsvila.com/36867464/the-fact-about-https-www-zosanopharma-com-technology-that-no-one-is-suggesting